Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure

BACKGROUND: Observational studies have demonstrated that treatment with sacubitril/valsartan may improve left ventricular (LV) systolic and diastolic function in subjects with reduced LV ejection fraction (LVEF) in real‐world studies. Subjects with heart failure and reduced EF (HFrEF), however, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Mazzeo, Pietro, Magnesa, Michele, Fortunato, Martino, Tricarico, Lucia, Leopizzi, Alessandra, Mallardi, Adriana, Mennella, Raffaele, Tucci, Salvatore, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292438/
https://www.ncbi.nlm.nih.gov/pubmed/34510702
http://dx.doi.org/10.1111/cpf.12726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292438/
https://www.ncbi.nlm.nih.gov/pubmed/34510702
http://dx.doi.org/10.1111/cpf.12726

Ejemplares similares